Notizia: The Latest Pharma, Healthcare and Biotech Event Archives
Fight Against the Antibiotic Resistance in the Uncomplicated Urinary Tract Infections Market
pharma-biotech-news-updates-for-biogen-smartlabs-synlogic-partner-therapeutics
Biogen’s AMD Biosimilar Gets Approval...

Win-win for Biogen as its Biosimilar Gets Approval for AMD  Samsung Bioepis and Biogen's biosimilar dr...

pharma-happenings-for-amylyx-beigene-roche-temedic-sage-therapeutics
FDA’s New Drug Application to ALS Dr...

FDA’s Go-Ahead to Amylyx New Drug Application for ALS Drug  Amylyx Pharmaceuticals has announced its p...

recent-pharma-news-updates-for-adarx-ixaka-novocure-vor-biopharma
ADARx Raises $75M Series B; Fast Trac...

ADARx bags USD 75 Million to advance its RNA tech pipeline ADARx Pharmaceuticals, a biotechnology company d...

pharma-news-updates-for-roche-mayo-clinic-owlstone-transmedics-google
Roche inks $3B deal; Owlstone raises $58M; FDA approves OCS heart system; Google, Mayo Clinic bui...

Roche’s Genentech taps Adaptimmune for T-Cell Therapy Collaboration for USD 3 BillionA collaboration valued more than USD 3 billion, Genentech, a member of the Roche Group, declared it will co...


recent-pharma-news-and-updates-for-Pfizer-Forte-Biosciences- Bone-Therapeutics-Versanis-Bio-AC-Immune
Pfizer’s RSV Vaccine; Forte Biosciences’ Atopic Dermatitis Asset; Bone Therapeutics’ Osteoarthrit...

Pfizer’s RSV Vaccine enters in the late-stage of clinical trials As the battle to get an effective Respiratory Syncytial Virus (RSV) vaccine on the market heats up, Pfizer is launching a ...


medtech-news-and-updates-for-abiomed-helius-smart-meter-bd-veritor-xact
Abiomed’s Impella ECP; Helius’s PoNS Device; Smart Meter’s iGlucose BGM; XACT’s CT-Guided Percuta...

FDA awards Breakthrough Device Designation to Impella ECP On August 18, 2021, Abiomed received breakthrough device designation from the United States Food and Drug Administration (FDA) fo...


pharma-news-and-updates-for-Ascendis-MicroTransponder-BioMarin-Zimmer-Biomet-Canary-Medical
Ascendis’s SKYTROFA; MicroTransponder’s VNS System (Vivistim); BioMarin’s Voxzogo; Zi...

FDA's Green Flag to Ascendis's Once-Weekly SKYTROFA for Treatment of Pediatric Growth Hormone DeficiencyFor the treatment of growth failure due to deficiency of growth hormones, the USFDA appr...


pharma-happenings-for-roche-allstripes-datavant-bluewillow-shape-therapeutics
Shape Therapeutics-Roche’s Deal; AllStripes Raises $50M; Datavant-Real Chemistry’s Pa...

Shape Therapeutics inks gene therapy deal with Roche worth up to USD 3 BillionSeattle biotech firm Shape Therapeutics has signed a deal potentially exceeding USD 3 billion with pharma giant Ro...


recent-pharma-news-updates-for-hebabiz-pfizer-astrazeneca-bms-masimo
AstraZeneca’s Ultomiris; HebaBiz’s Siroquine; Pfizer’s XELJANZ; Bristol Myers S...

AstraZeneca's Newly Occupied Alexion Hits Rock Bottom After Ultomiris (Ravulizumab) Fails to Show Efficacy in Patients with Amyotrophic Lateral SclerosisAstraZeneca's 39 billion USD complete a...


Chronic Obstructive Pulmonary Disease
Chronic Obstructive Pulmo...

According to WHO, Chronic Obstructive Pulmonary Disease (COPD) is the third leading cause of death g.....

Myelodysplastic Syndrome (MDS) Market Analysis
Myelodysplastic Syndrome ...

Well, MDS being one of the rare blood cancers, has been into the limelight of researchers since a de.....

Prostate Cancer
Prostate Cancer...

Prostate Cancer is the second most common malignancy in men worldwide, after lung cancer. Most Prost.....

Editor's Pick
Healthcare Data Breach: What it Means for Companies and the Consumer?

Data and analytics today are playing a major role in the organization’s growth. Stakeho...

Onychomycosis Therapy Market Set to Balloon Up as Emerging Novel Therapies Co...

Onychomycosis is the most commonly prevalent nail infection in adults. It is a fungal i...

Angelman syndrome Pipeline: Unmet needs call for a robust pipeline

The necessity of a robust Angelman syndrome pipeline is indispensable at the current mo...

The New Buzz of Transcranial Stimulation Devices in the Neurological Disorder...

Neurological disorders are one of the major causes of death and disability across the g...

Leading Autoimmune Diseases to Undergo Robust Improvement in Treatment by Maj...

As per the American Autoimmune Related Diseases Association (AARDA), nearly 50 million ...